Sven Wind
Impact in
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 11
- Oncology 12
- HER2/EGFR in Cancer Research 10
- Co-authors
- Harald H.H.W. Schmidt (3 shared papers)Eduardo Barbosa‐Sicard (1 shared paper)Katrin Schröder (1 shared paper)Ralf Peter Brandes (1 shared paper)Rudi Busse (1 shared paper)Sabine Heumüller-Klug (1 shared paper)Peter Stopfer (8 shared papers)Matthias Freiwald (3 shared papers)
- Journals
- Annals of Oncology (5 papers)Clinical Pharmacokinetics (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Hypertension (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Sven Wind
33 papers receiving 2.4k citations
Sven Wind's Hit Papers
Peers
Comparison fields: 5 of 82
- Physiology 504
- Pulmonary and Respiratory Medicine 566
- Pharmacology 152
- Genetics 135
- Oncology 289
Countries citing papers authored by Sven Wind
This map shows the geographic impact of Sven Wind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Wind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Wind more than expected).
Fields of papers citing papers by Sven Wind
This network shows the impact of papers produced by Sven Wind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Wind. The network helps show where Sven Wind may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Wind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant Hit paper breakdown → | 2007 | 670 |
| 2 | 2010 | 221 | |
| 3 | 2012 | 169 | |
| 4 | 2016 | 161 | |
| 5 | 2019 | 160 | |
| 6 | 2016 | 159 | |
| 7 | 2010 | 153 | |
| 8 | 2014 | 152 | |
| 9 | 2013 | 80 | |
| 10 | 2012 | 75 | |
| 11 | 2012 | 66 | |
| 12 | 2014 | 56 | |
| 13 | 2014 | 46 | |
| 14 | 2018 | 36 | |
| 15 | 2014 | 34 | |
| 16 | 2017 | 33 | |
| 17 | 2013 | 32 | |
| 18 | 2018 | 28 | |
| 19 | 2018 | 25 | |
| 20 | 2016 | 18 |
About Sven Wind
Sven Wind is a scholar working on Pharmacology, Oncology, Pulmonary and Respiratory Medicine, Biochemistry and Physiology, having authored 33 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), HER2/EGFR in Cancer Research (10 papers), Lung Cancer Treatments and Mutations (9 papers), Nitric Oxide and Endothelin Effects (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Schizophrenia research and treatment (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Physiology (504 citations), Pulmonary and Respiratory Medicine (566 citations), Pharmacology (152 citations), Genetics (135 citations) and Oncology (289 citations). Sven Wind has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Harald H.H.W. Schmidt, Eduardo Barbosa‐Sicard, Katrin Schröder, Ralf Peter Brandes, Rudi Busse, Sabine Heumüller-Klug, Peter Stopfer, Matthias Freiwald, Thomas Ebner and Melanie E. Armitage. Their work appears in journals such as Annals of Oncology, Clinical Pharmacokinetics, Cancer Chemotherapy and Pharmacology, Hypertension and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.